phosphorylcholine has been researched along with Keratitis, Acanthamoeba in 16 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to report a retrospective case series of anterior scleral and limbal inflammatory necrosis after adjuvant miltefosine for recalcitrant Acanthamoeba keratitis (AK)." | 8.12 | Anterior Scleral and Limbal Inflammatory Necrosis After Adjuvant Miltefosine for Recalcitrant Acanthamoeba Keratitis. ( Berdahl, J; de la Presa, M; Holland, EJ; Ibach, M, 2022) |
| "To report a case series of patients with treatment-resistant Acanthamoeba keratitis (AK) using oral miltefosine, often as salvage therapy." | 8.02 | Oral Miltefosine as Salvage Therapy for Refractory Acanthamoeba Keratitis. ( Appenheimer, AB; Chodosh, J; Hou, JH; Kang, JJ; Morrill, AM; Rapuano, CJ; Saeed, HN; Thulasi, P; Tu, EY; Vyas, N; Zegans, ME; Zuckerman, R, 2021) |
| "This case shows resolution of recalcitrant Acanthamoeba keratitis with oral miltefosine in an immunocompetent patient." | 7.91 | Oral Miltefosine as Adjunctive Treatment for Recalcitrant Acanthamoeba Keratitis. ( Dewan, N; Holland, SP; Iovieno, A; Ming, W; Yeung, SN, 2019) |
| "In this study, a series of compounds - miltefosine, polyhexamethylene biguanide, chlorhexidine and propamidine isethionate - and combinations of the latter three agents with miltefosine were prepared and used in a rat model for the topical treatment of Acanthamoeba keratitis." | 7.80 | Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis. ( Arici, MK; Dursun, A; Obwaller, A; Polat, ZA; Vural, A; Walochnik, J, 2014) |
| "Miltefosine treatment yielded much higher cure scores than propamidine isetionate plus polyhexanide." | 5.38 | Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters. ( Obwaller, A; Polat, ZA; Vural, A; Walochnik, J, 2012) |
| "The treatment of Acanthamoeba keratitis has now been possible since the first successful therapy developed in the mid 1980s with a combination of propamidine 0." | 4.82 | Treatment of Acanthamoeba keratitis. ( Seal, D, 2003) |
| "The purpose of this study was to report a retrospective case series of anterior scleral and limbal inflammatory necrosis after adjuvant miltefosine for recalcitrant Acanthamoeba keratitis (AK)." | 4.12 | Anterior Scleral and Limbal Inflammatory Necrosis After Adjuvant Miltefosine for Recalcitrant Acanthamoeba Keratitis. ( Berdahl, J; de la Presa, M; Holland, EJ; Ibach, M, 2022) |
| "To report a case series of patients with treatment-resistant Acanthamoeba keratitis (AK) using oral miltefosine, often as salvage therapy." | 4.02 | Oral Miltefosine as Salvage Therapy for Refractory Acanthamoeba Keratitis. ( Appenheimer, AB; Chodosh, J; Hou, JH; Kang, JJ; Morrill, AM; Rapuano, CJ; Saeed, HN; Thulasi, P; Tu, EY; Vyas, N; Zegans, ME; Zuckerman, R, 2021) |
| "This case shows resolution of recalcitrant Acanthamoeba keratitis with oral miltefosine in an immunocompetent patient." | 3.91 | Oral Miltefosine as Adjunctive Treatment for Recalcitrant Acanthamoeba Keratitis. ( Dewan, N; Holland, SP; Iovieno, A; Ming, W; Yeung, SN, 2019) |
| "In this study, a series of compounds - miltefosine, polyhexamethylene biguanide, chlorhexidine and propamidine isethionate - and combinations of the latter three agents with miltefosine were prepared and used in a rat model for the topical treatment of Acanthamoeba keratitis." | 3.80 | Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis. ( Arici, MK; Dursun, A; Obwaller, A; Polat, ZA; Vural, A; Walochnik, J, 2014) |
| "Acanthamoeba keratitis is a corneal disease associated predominantly with contact lens wear." | 2.42 | [Treatment of Acanthamoeba keratitis: possibilities, problems, and new approaches]. ( Aspöck, H; Duchêne, M; Eibl, H; Walochnik, J, 2003) |
| "Miltefosine treatment yielded much higher cure scores than propamidine isetionate plus polyhexanide." | 1.38 | Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters. ( Obwaller, A; Polat, ZA; Vural, A; Walochnik, J, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 7 (43.75) | 2.80 |
| Authors | Studies |
|---|---|
| de la Presa, M | 1 |
| Ibach, M | 1 |
| Berdahl, J | 1 |
| Holland, EJ | 1 |
| Avdagic, E | 1 |
| Chew, HF | 1 |
| Veldman, P | 1 |
| Tu, EY | 3 |
| Jafri, M | 1 |
| Doshi, R | 1 |
| Boggild, AK | 1 |
| Reidy, JJ | 2 |
| Farooq, AV | 2 |
| Thulasi, P | 2 |
| Saeed, HN | 1 |
| Rapuano, CJ | 1 |
| Hou, JH | 1 |
| Appenheimer, AB | 1 |
| Chodosh, J | 1 |
| Kang, JJ | 1 |
| Morrill, AM | 1 |
| Vyas, N | 1 |
| Zegans, ME | 1 |
| Zuckerman, R | 1 |
| Si, Z | 1 |
| Veldman, PB | 1 |
| Kaur, A | 1 |
| Sahu, SK | 1 |
| Matoba, A | 1 |
| Weikert, MP | 1 |
| Kim, S | 1 |
| Bagga, B | 1 |
| Joseph, J | 1 |
| Garg, P | 1 |
| Chandran, K | 1 |
| Jayabhasker, P | 1 |
| Manjulatha, K | 1 |
| Sharma, S | 1 |
| Dewan, N | 1 |
| Ming, W | 1 |
| Holland, SP | 1 |
| Yeung, SN | 1 |
| Iovieno, A | 1 |
| Polat, ZA | 2 |
| Walochnik, J | 4 |
| Obwaller, A | 3 |
| Vural, A | 2 |
| Dursun, A | 1 |
| Arici, MK | 1 |
| Mrva, M | 1 |
| Garajová, M | 1 |
| Lukáč, M | 1 |
| Ondriska, F | 1 |
| Seal, D | 1 |
| Duchêne, M | 2 |
| Eibl, H | 2 |
| Aspöck, H | 2 |
| Vasseneix, C | 1 |
| Gargala, G | 1 |
| François, A | 1 |
| Hellot, MF | 1 |
| Duclos, C | 1 |
| Muraine, M | 1 |
| Benichou, J | 1 |
| Ballet, JJ | 1 |
| Brasseur, G | 1 |
| Favennec, L | 1 |
| Seifert, K | 1 |
| Hottkowitz, T | 1 |
| Wiedermann, G | 1 |
2 reviews available for phosphorylcholine and Keratitis, Acanthamoeba
| Article | Year |
|---|---|
Treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Amebicides; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antiprotozo | 2003 |
[Treatment of Acanthamoeba keratitis: possibilities, problems, and new approaches].
Topics: Acanthamoeba Keratitis; Antiprotozoal Agents; Benzamidines; Biguanides; Contact Lens Solutions; Cont | 2003 |
14 other studies available for phosphorylcholine and Keratitis, Acanthamoeba
| Article | Year |
|---|---|
Anterior Scleral and Limbal Inflammatory Necrosis After Adjuvant Miltefosine for Recalcitrant Acanthamoeba Keratitis.
Topics: Acanthamoeba Keratitis; Adjuvants, Immunologic; Adult; Humans; Inflammation; Necrosis; Phosphorylcho | 2022 |
Resolution of
Topics: Acanthamoeba; Acanthamoeba Keratitis; Administration, Oral; Adult; Antiprotozoal Agents; Cornea; DNA | 2021 |
Oral Miltefosine as Salvage Therapy for Refractory Acanthamoeba Keratitis.
Topics: Acanthamoeba Keratitis; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiprotoz | 2021 |
Severe Inflammatory Response in a Patient on Oral Miltefosine for Acanthamoeba Keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Humans; Phosphorylcholine | 2022 |
Comment on "Oral Miltefosine as Salvage Therapy for Refractory Acanthamoeba Keratitis".
Topics: Acanthamoeba; Acanthamoeba Keratitis; Humans; Phosphorylcholine; Salvage Therapy | 2021 |
Reply to Comment on "Oral Miltefosine as Salvage Therapy for Recalcitrant Acanthamoeba Keratitis".
Topics: Acanthamoeba; Acanthamoeba Keratitis; Humans; Phosphorylcholine; Salvage Therapy | 2021 |
Corneal Manifestations of Miltefosine Toxicity in Acanthamoeba Keratitis.
Topics: Acanthamoeba Keratitis; Anti-Allergic Agents; Antiprotozoal Agents; Corneal Stroma; Drug Substitutio | 2021 |
Efficacy of Topical Miltefosine in Patients with Acanthamoeba Keratitis: A Pilot Study.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Animals; Antiprotozoal Agents; Cornea; Eye Infections, | 2019 |
Oral Miltefosine as Adjunctive Treatment for Recalcitrant Acanthamoeba Keratitis.
Topics: Acanthamoeba Keratitis; Administration, Oral; Adult; Antiprotozoal Agents; Chemotherapy, Adjuvant; C | 2019 |
Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Antiprotozoal Agents; Biguanides; Cell Line; Cell Pro | 2014 |
Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp.
Topics: Acanthamoeba; Acanthamoeba castellanii; Acanthamoeba Keratitis; Antiprotozoal Agents; Cornea; Dose-R | 2011 |
Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Administration, Topical; Animals; Antiprotozoal Agents; Benzam | 2012 |
A keratitis rat model for evaluation of anti-Acanthamoeba polyphaga agents.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Administration, Topical; Animals; Antiprotozoal Agents; Benzam | 2006 |
Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Alkanes; Amebicides; Animals; Cell Survival; Hexokinase; Human | 2002 |